Prof. Yves Henrotin, Professor at the University of Liège (Belgium), Head of the Physical Therapy & Rehabilitation Department at the Princesse Paola Hospital (Belgium).

In this episode, Prof. Yves Henrontin, a world renowned expert in the OA field shares his opinion on key aspects around this disease, such as the increase in incidence, prevalence, rising risk factors and comorbidities that OA patients are facing. This is a general update in OA you won’t want to miss.

Dr. Gustavo Constantino de Campos, PHD PHD in Trauma Orthopedics and Member of the Orthopedics and Traumatology Dept. at the University of Campinas (Brazil).

Dr. Gustavo Constantino de Campos and our host Dr. Simon Fleming help us to understand, step-by-step, the implications and mechanical impact of OA on patient’s lives and how this pathology can affect even the simplest activities due to disability or restricted mobility caused by pain.

Mrs. Céline Mathy, Clinical psychologist and Guidance counsellor at the University of Liège (Belgium).

Mrs. Céline Mathy will make a deep dive into the different coping mechanisms for those living with OA, from a psychological perspective. She will guide us through the identification of signs related to depression in OA patients, as well as how we can take actions early to benefit patient’s quality of life.

In this episode, you will have the chance to listen exclusively from a patient about how osteoarthritis has affected her life.

This is Monique, 80 years old, who has lived with osteoarthritis for most of her life, and who has agreed to share her journey with the medical community. She will talk about how she has seen her osteoarthritis progress and the impact of this disease on her mobility and daily activities. This is a reminder to us, as healthcare professionals, of the importance of the patient journey and our responsibility to continue to explore opportunities to find ways to improve the quality of life of patients.

Prof. Ali Mobasheri, President of the Osteoarthritis Research Society International, OARSI.

What is a serious disease and why is Osteoarthritis a serious disease? Prof. Ali Mobasheri, walks us through the OARSI White Paper submission, the key and future steps to find ways to make this serious disease that is chronic feel more acute. But, why was OA not considered a serious disease before? What impact does this new classification have in the way we treat patients? This and more in this episode!

Dr. Anthony Criquet, Former Global Medical Affairs Director at Laboratoires Expanscience

What’s next and where is OA management and treatment headed? Join Dr. Anthony Criquet as he shares the key scientific information regarding the highlights on Osteoarthritis from the OARSI & EULAR Congresses in 2021.

Dr. Luis Vidal, Director of the Rheumatology Department at María Auxiliadora Hospital (Peru) and Medical Director of CEDOR

Dr. Luis Vidal seeks to show young doctors the importance of diagnosing OA, from general to more specific aspects that will help differentiate OA from other types of arthritis. Today, Dr. Vidal and Dr. Flemming will walk us through the symptoms, journeys, guidelines, grades and severity of this disease stressing a key factor: the difference an early, fast and correct diagnosis can make for a patient’s life in the short and long term.

Prof. Fadoua Allali, Director of the Rheumatology Department at the El Ayachi Hospital.

Ever heard of WOMAC & LEQUESNE indexes? On this episode, Prof. Fadoua Allali will explain how to use these and other OA indexes to measure the patient’s pain and support doctors in the diagnosis and follow up process. Dr. Allali will give tips and recommendations for the use of these tools and explain how they work to better monitor the patient’s disease progression and how to interpret the data as a guidance to adapt the treatment to new circumstances, if necessary. Dr. Allali has confirmed her participation in a future episode so we hope you’ll continue to join us in Let’s Talk OA

Prof. Fadoua Allali, Director of the Rheumatology Department at the El Ayachi Hospital.

Prof. Fadoua Allali is back joining Dr. Simon Fleming as they break down false myths and non-official advice on nutrition and obesity in Osteoarthritis. You won’t believe the things Dr. Allali has heard because sometimes, patient don’t check their sources! Listen along to gather advice and recommendations on avoiding misleading information.

Prof. Kim Bennell, Professor Redmond Barry NHMRC Research Fellow in the Department of Physiotherapy at the University of Melbourne.

On this episode, Professor Kim Bennell joins us from Australia to discuss the role and importance of physical exercise in the treatment of OA. She will be sharing some helpful tips and recommendations that doctors with OA patients can include in their day-to-day clinical practice to help patients better integrate exercise in their daily life. It is a common misconception that for joint pain, rest is best when in most cases, staying active would help provide the best results in the short and long-term.

Patient adherence to pharmacological and non-pharmacological treatment is something physicians often struggle with, and OA is no exception. Listen to this podcast with Dr. Chalem and Pilar, an osteoarthritis patient, to understand why OA patients do or do not follow recommended treatments. Together they will help us gather some key takeaways to better understand and support our OA patients within the clinic, but also beyond its walls. Thank you, Pilar & Monique, for this wonderful discussion.

Dr. Pascal Hilliquin, Dr. Pascal Hilliquin Head of Rheumatology Department, South Francilien Hospital Centre

Dr. Pascal Hilliquin, who is Head of the Rheumatology Department at the Central Hospital of Southern Paris in Corbeil-Essonnes in France, is joining “Let’s Talk OA” to talk about how NSAIDs recommendations change in the short, mid and long term scenarios as well as in the earlier stages of OA. Although each patient should always be analysed individually, there are many general aspects you won’t want to miss. Dr. Hilliquin will be joining us on another episode so stay tuned for more.

Dr. Andrés Silberman,Traumatologist – Orthopaedic Physician

Dr. Juan Carlos Cajigas, Rheumatologist

Drs. Andrés Silberman and Juan Carlos Cajigas join “Let’s Talk OA” to discuss the optimal timing for operating on patients with OA, along with Dr. Simon Fleming, our host for this podcast series.

Dr. Andrés Silberman,Traumatologist – Orthopaedic Physician

Dr. Juan Carlos Cajigas, Rheumatologist

Some surgeons choose early surgery, while others prefer to exhaust all treatment options in a hierarchical order. The conclusion is clear: adopting a patient-centered approach that can be tailored to their lifestyle, needs, and pain levels. All crucial aspects for this decision-making process.

Dr. Noel Carilo, Orthopedic Surgeon specialized in Orthopedic Traumatology of the hand and microsurgery.

Dr. Simon Fleming and orthopedic surgeon Dr. Noel Carilo, discuss the post-surgical action process in patients with osteoarthritis. They cover topics such as the type of patients likely to be operated on, the various possible interventions, the treatments to be followed postoperatively or the assistance to be provided to patients in the recovery process.

Prof. Yves Henrotin, Professor at the University of Liège (Belgium)

Prof. Yves Henrotin is back to help us understand the role of Patient Associations and Societies in innovation and support for patients with osteoarthritis. In previous podcasts we have already talked about the different types of treatment for this pathology. In this episode, we will discover the essential role of patient associations in decision-making, particularly at the international level.

Dr. Demirhan Dıraçoğlu, Professor of the Faculty of Medicine, Faculty of Physical Medicine and Rehabilitation, Istanbul University

Early detection of OA is essential to prevent progression into the most advanced stages of the disease. Dr. Demirhan Dıraçoğlu, Professor at the Faculty of Medicine in the University of Istanbul and member of various groups focused on osteoarthritis, joins “Let’s Talk OA” to tell us why early OA is key for patients’ outcomes in terms of quality of life.

Mrs. Françoise Alliot-Launois, President of AFLAR (Association Française Contre le Rheumatisme)

One of the greatest challenges in the lives of patients with osteoarthritis is undoubtedly that they suffer from a disease invisible to the naked eye. Several international associations and foundations take the awareness of osteoarthritis very seriously and make it one of their main missions. In this episode, Mrs. Françoise Alliot will share some of the initiatives and activities carried out internationally with other associations, healthcare professionals, public entities, and other stakeholders in the field of osteoarthritis.

Prof. Gregory Ninot, PhD in Sports Science and Psychology, Associate Director, Desbrest Institute of Epidemiology and Public Health

Professor Gregory Ninot will share a different approach to osteoarthritis by explaining how non-conventional or non-pharmacological interventions can help patients with osteoarthritis.

Dr. Ivone Karina Ruiz López, Medical Director of the General Hospital of Mexico “Dr. Eduardo Liceaga”.

Two years after the COVID-19 pandemic, the EULAR (European Alliance of Associations for Rheumatology) congress returned to a face-to-face format this summer 2022. To tell us about it, we welcome rheumatologist Dr. Ivone Karina Ruiz Lopez. In this episode, she will share the main highlights from the congress as a personal review of the sessions she attended. Dr. Ruiz is Vice Principal Medical Director at the General Hospital of Mexico “Dr. Eduardo Liceaga” and Executive Secretary of the Mexican College of Rheumatology AC.

Mrs. Céline Mathy, Clinical Psychologist and General Director of the Arthrose Foundation

Mrs. Céline Mathy joins us today to present the results of the Stop Arthrose 2019-2021 patient study. This study, conducted in Belgium and France, showcases the progression of osteoarthritis from the perspective of the patients. This, in contrast to the previous wave and Mrs. Mathy’s clinical experience as a psychologist, may lead us to a better understanding of why significant advances in osteoarthritis seem to be… stalled.

Dr. Andres Silberman, Professor of Orthopedics and Tramulatology, School of Medicine, University of Buenos Aires

Dr Andrés Silberman explains the importance of adherence in osteoarthritis by looking at the evolution of adherent and non-adherent patients. He will also explain the different ways of measuring adherence in osteoarthritis and what actions can be done to help patients become more adherent.

Dr. Yusuf Erdem, Orthopedic surgeon at the Gulhane Information and Research Hospital.

To date, is little known about the genetic backgroun of OA. Today we have the opportunity to listen to our guest, Dr. Yusuf Erdem, Orthopaedic surgeon in Gulhane Training and Research Hospital. He will share with us if there is any scientific evidence that associates genes with risks of developing OA, understand what is the rol of genetics behind this disease.